Lifestyle-related risk factors for Parkinson's disease: A population-based study

Acta Neurologica Scandinavica

Volumn 108, Issue 4, 2003, Pages 239-244

  Baldereschi, Marzia ^a,e   Di Carlo, A ^a   Vanni, P ^b   Ghetti, A ^c   Carbonin, P ^d   Amaducci, L ^b   Inzitari, D ^b  

^a CNR   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c Health Area 10   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e Dip Scienze Neurologiche   (Italy)

Author keywords

Parkinson's disease; Pesticide; Risk factors

Indexed keywords

PESTICIDE;

AGED; AGING; ARTICLE; CLINICAL EXAMINATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; ITALY; LICENCE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MULTIVARIATE ANALYSIS; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PARKINSONISM; PESTICIDE SPRAYING; POPULATION EXPOSURE; POPULATION RESEARCH; PREVALENCE; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING;

AGED; AGED, 80 AND OVER; AGING; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; ITALY; LIFE STYLE; LONGITUDINAL STUDIES; MALE; PARKINSON DISEASE; PREVALENCE; RISK FACTORS; RISK-TAKING;

EID: 0141566328     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2003.00128.x     Document Type: Article

References (36)

1. SEIDLER A, HELLENBRAND W, ROBRA BP et al. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case control study in Germany. Neurology 1996;46:1275-84.
2. GRANDINETTI A, MORENS DM, REED D, MACEACHEM D. Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. Am J Epidemiol 1994;139:1129-38.
3. MAYEUX R, TANG MX, MARDER K, COTE LJ, STERN Y. Smoking and Parkinson's disease. Mov Disord 1994;9:207-12.
4. TZOURIO C, ROCCA WA, BRETELER MMB et al. Smoking and Parkinson's disease. An age-dependent risk effect? Neurology 1997;49:1267-72.
5. LIOU HH, TSAI MC, CHEN CJ et al. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 1997;48:1583-8.
6. HUBBLE JP, CAO T, HASSANEIN RE, NEUBERGER JS, KOLLER WC. Risk factors for Parkinson's disease. Neurology 1993;43:1693-7.
7. SEMCHUCK KM, LOVE EJ, LEE RG. Parkinson's disease and exposure to agricultural work and pesticide chemicals. Neurology 1992;41:1328-35.
8. WOOD N. Genes and parkinsonism. J Neurol Neurosurg Psychiatry 1997;62:305-9.
9. MARDER K, LOGROSCINO G, ALFARO B et al. Environmental risk factors for Parkinson's disease in an urban multiethnic community. Neurology 1998;50:279-81.
10. MAGGI S, ZUCCHETTO M, GRIGOLETTO F et al. for the ILSA Group. The Italian Longitudinal Study on Aging (ILSA): design and methods. Aging Clin Exp Res 1994;6:464-73.
11. FAHN S, ELTON RL, Members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: FAHN S, MARSDEN CD, CALNE DB, eds. Recent developments in Parkinson's disease, Vol. 2. Florham Park, NJ: MacMillan Healthcare Information, 1987;153-63.
12. NORUSIS MJ. SPSS for Windows. Base system user's guide and advanced statistics. Release 6.0. Chicago, IL: SPSS Inc., 1993.
13. FRATIGLIONI L, WANG HX. Smoking and Parkinson's and Alzheimer's disease: review of the epidemiological studies. Behav Brain Res 2000;113:117-20.
14. MORENS DM, GRANDINETTI A, DAVIS JW, ROSS GW, WHITE LR, REED D. Evidence against the operation of selective mortality in explaining the association between cigarette smoking and reduced occurrence of idiopathic Parkinson disease. Am J Epidemiol 1996;144:400-4.
15. DIANA JN. Tobacco smoking and nutrition. Ann NY Acad Sci 1993;686:1-11.
16. JANSON AM, MOLLER A. Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemitransection: an analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat. Neuroscience 1993;57:931-41.
17. JAMES JR, NORDBERG A. Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer's disease and Parkinson's disease. Behav Genet 1995;25:149-59.
18. SHAHI GS, DAS NP, MOOCHHALA SM. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: partial protection against striato-nigral dopamine depletion in C57BL/6J mice by cigarette smoke exposure and by beta-naphthoflavone-pretreatment. Neurosci Lett 1991;127:247-50.
19. CHAN DKY, WOO J, HO SC et al. Genetic and environmental risk factors for Parkinson's disease in a Chinese population. J Neurol Neurosurg Psychiatry 1998;65:781-4.
20. FALL PA, FREDRIKSON M, AXELSON O, GRANERUS AK. Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden. Mov Disord 1999;14:28-37.
21. RITZ B, YU F. Parkinson's disease mortality and pesticide exposure in California 1984-1994. Int J Epidemiol 2000;29:323-9.
22. JIMENEZ-JIMENEZ FJ, MATEO D, GIMENEZ-ROLDAN S. Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: a case-control study. Mov Disord 1992;7:339-44.
23. TAYLOR CA, SAINT-HILAIRE MH, CUPPLES LA et al. Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study. Am J Med Genet 1999;88:742-9.
24. KUOPIO AM, MARTTILA RJ, HELENIUS H, RINNE UK. Environmental risk factors in Parkinson's disease. Mov Disord 1999;14:928-39.
25. BETARBET R, SHERER TB, MACKENZIE G, GARCIA-OSUNA M, PANOV AV, GREENAMYRE JT. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 2000;3:1301-6.
26. HART TB. Parkinson's disease and pesticides (Letter). Lancet 1987;1:38.
27. PERRY EK, PERRY RH, SMITH CJ et al. Cholinergic receptors in cognitive disorders. Can J Neurol Sci 1986;13:521-7.
28. SANCHEZ-RAMOS JR, HEFTI F, WEINER WJ. Paraquat and Parkinson's disease (Letter). Neurology 1987;37:728.
29. LE COUTEUR DG, MCLEAN AJ, TAYLOR MC, WOODHAM BL, BOARD PG. Pesticides and Parkinson's disease. Biomed Pharmacother 1999;53:122-30.
30. BHATT MH, ELIAS MA, MANKODI AK. Acute and reversible parkinsonism due to organophosphate pesticide intoxication: five cases. Neurology 1999;52:1467-71.
31. MENEGON A, BOARD PG, BLACKBURN AC, MELLICK GD, LE COUTEUR DG. Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet 1998;352:1344-6.
32. BALDERESCHI M, DI CARLO A, ROCCA WA et al. for the ILSA Working Group. Parkinson's disease and parkinsonism in a longitudinal study. Two-fold higher incidence in men. Neurology 2000;55:1358-63.
33. SAWADA H, SHIMOHAMA S. Neuroprotective effects of estradiol in mesencephatic dopaminergic neurons. Neurosci Biobehav Rev 2000;24:143-7.
34. MILLER DB, ALI SF, O'CALLAGHAN JP, LAWS SC. The impact of gender and estrogen on striatal dopaminergic neurotoxicity. Ann NY Acad Sci 1998;844:153-65.
35. GREEN PS, SIMPINKS JW. Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci 2000;18:347-58.
36. SACKETT DL. Bias in analytic research. J Chronic Dis 1979;32:51-63.